Psychiatry Information in Brief

Article Title

Protecting Research Participants: How Can We Reduce “Therapeutic Misconception" in Clinical Research Trials? [English and Spanish versions]

Authors

Charles W. Lidz, University of Massachusetts Medical SchoolFollow
Debbie Truong, University of Massachusetts Medical SchoolFollow
Karen Albert, University of Massachusetts Medical SchoolFollow
Shums Alikhan, University of Massachusetts Medical SchoolFollow

Document Type

Research in the Works

Publication Date

2017-3

DOI

10.7191/pib.1109

Abstract

A Spanish translation of this publication is available to download under "Additional Files" below.

Therapeutic Misconception and Scientific Reframing is a National Institute of Mental Health funded study led by Charles Lidz, Ph.D. The study’s goals are to: (1) Develop an innovative procedure that educates participants about clinical research trials to reduce Therapeutic Misconception (TM); and (2) Test this innovative procedure in a hypothetical clinical research trial to reduce TM without reducing study enrollment rates.

Subject Area

Ethics

Keywords

Therapeutic Misconception, Clinical Trials Ethics, Scientific Reframing, Spanish

Repository Citation

Lidz CW, Truong D, Albert K, Alikhan S. Protecting Research Participants: How Can We Reduce “Therapeutic Misconception" in Clinical Research Trials? [English and Spanish versions]. Psychiatry Information in Brief 2017;14(2):1109. https://doi.org/10.7191/pib.1109. Retrieved from https://escholarship.umassmed.edu/pib/vol14/iss2/1

Creative Commons License

This work is licensed under a Creative Commons Attribution-Noncommercial-Share Alike 3.0 License.